Navigation Links
New Drug Mix to Extend Life of Transplanted Kidneys

It is great news for kidney recipients as well as those on the waiting list. Scientists now announce the extended life spans of transplanted kidneys// by a priceless two times, through a mix of varied drugs.

Scientists from the University Hospital in Cardiff who detailed their work in an organ transplant study entitled ‘Symphony’, say a combination of drugs including the standard one CellCept, will do the trick. The study involved 1,645 kidney patients from 15 countries.

It was seen that early organ rejection was reduced by 52 percent compared with the other combinations tested, with far less toxic side effects.

Consequentially, it was predicted that the normal 10-year lifespan of a transplanted kidney would be extended to 20 years or more.

The scientists reported that used across the UK, the treatment protocol could save the NHS more than 100 kidneys a year. In addition, lesser transplant patients with "old" organs would have to be found new replacements, easing the pressure on waiting lists. The number of patients without functioning kidneys having to rely on dialysis would also be reduced, the scientists stressed.

Between 2005 and 2006, a total of 1,783 British patients received new kidneys.

The NHS list of patients waiting for new kidneys now stands at 5,971, but the total number of people in the UK needing a kidney, including those who do not meet the strict criteria for transplants laid down by the NHS, is estimated to be about 20,000.
AN
'"/>




Page: 1

Related medicine news :

1. Extended Therapy for Blood Clots
2. Genes to Extend Longevity Discovered
3. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
4. Drug Courts In Europe Extended For Three More Years
5. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
6. Extend Workers Compensation To Firefighters. Pleads Son
7. Boots Store Also Extend Its Services to the Hospital Sector
8. Damage Due to MS Might Extend Into Larger Portions Of The Normal Brain
9. Imperative to Extend Reach of Federal Health Insurance Schemes for children
10. Tenure of Mental Health CommissionExtended
11. Irish Medicines Board Extends Paracetamol Recall To All Batches
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... , ... June 26, 2017 , ... Antoine Dental Center is now offering ... in tooth replacement and act as a support for prosthetic teeth, such as crowns, bridges, ... existing bone and becomes a sturdy, lasting new root for the tooth. , Several ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... a recent review of government data released by the United Soybean Board. ... practices, Maryland’s soybean farmers have increased their productivity on less land per bushel, ...
(Date:6/26/2017)... TX (PRWEB) , ... June 26, 2017 , ... ... their coding staff, and consumers are seeing lots of red these days. According ... contain inaccurate charges that result from medical coding errors(1). Some studies point to ...
(Date:6/25/2017)... ... June 25, 2017 , ... FCPX LUT Vintage Volume 2 for Final Cut ... LUT Vintage Volume 2 contains 60 different color-grade presets, giving editors multiple options for ... blurs to single out subjects, plus much more. FCPX LUT Vintage Volume 2 is ...
(Date:6/25/2017)... , ... June 25, 2017 , ... An increase in ... growing foliage and plants, and along with that; a humdinger of an allergy season. ... it also means an increase in misery-causing grass and weed pollen. , “Our ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... 5, 2017 The Cincinnati ... Pharmacy, Inc. (NYSE: DPLO), has been awarded a Top ... Results are based on an employee survey administered ... and workplace improvement. The survey measures several aspects of workplace ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: